Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT Plus Standard First-Line Therapy for Unresectable Colorectal Cancer
NCT07509398Phase 3Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in colorectal cancer (CRC), sponsored by Shanghai Tenth People's Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07509398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07509398.